Montreal Children's Hospital is a children's hospital in Montreal, Quebec, Canada. Founded in 1904, it is affiliated with the McGill University Health Centre and McGill University, Faculty of Medicine. The hospital has 154 single-patient rooms, 52-bed neonatology unit, 6 operating rooms and 6 intervention rooms.

There are 154 beds in Montreal Children's Hospital at McGill University Health Center.

During the past decade, Montreal Children's Hospital at McGill University Health Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Montreal Children's Hospital at McGill University Health Center" #1 sponsor was "Children's Oncology Group" with 54 trials, followed by "National Cancer Institute (NCI)" with 6 trials sponsored, "QLT Inc." with 4 trials sponsored, "McGill University Health Centre/Research Institute of the McGill University Health Centre" with 2 trials sponsored and "Ultragenyx Pharmaceutical Inc" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Montreal Children's Hospital at McGill University Health Center" #1 collaborator was "National Cancer Institute (NCI)" with 56 trials as a collaborator, "Children's Oncology Group" with 3 trials as a collaborator, "Crohn's and Colitis Foundation" with 1 trials as a collaborator, "SWOG Cancer Research Network" with 1 trials as a collaborator and "Terry Fox Foundation" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Montreal Children's Hospital at McGill University Health Center" are "Leukemia" (16 trials), "Sarcoma" (14 trials), "Lymphoma" (11 trials), "Unspecified Childhood Solid Tumor, Protocol Specific" (9 trials) and "Neuroblastoma" (8 trials). Many other conditions were trialed in "Montreal Children's Hospital at McGill University Health Center" in a lesser frequency.

Most popular intervention types in "Montreal Children's Hospital at McGill University Health Center" are "Drug" (58 trials), "Biological" (28 trials), "Procedure" (20 trials), "Radiation" (15 trials) and "Other" (7 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (20 trials), "filgrastim" (19 trials), "etoposide" (18 trials), "vincristine sulfate" (18 trials) and "radiation therapy" (14 trials). Other intervention names were less common.

The vast majority of trials in "Montreal Children's Hospital at McGill University Health Center" are 71 trials for "All" genders.

Currently, there are NaN active trials in "Montreal Children's Hospital at McGill University Health Center". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 66 completed trials in Montreal Children's Hospital at McGill University Health Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Montreal Children's Hospital at McGill University Health Center, 14 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".